You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
GenapSys will offer the Twist Bioscience products to customers of its recently launched low-cost, portable DNA sequencing system.
Among the firm's distributors in the Asia-Pacific region are Research Instruments of Singapore, Biomedical Systems of Korea, and Gene Company of Hong Kong.
On the second day of the conference, updates came not just from the publicly traded industry giants but also privately held firms of interest, such as Caris and GenapSys.
Researchers at the Jackson Laboratory have tested an early version of the GenapSys sequencer and found it to have a very low mismatch error rate.
The Redwood, California-based company plans to use the funding to drive the commercial launch of its semiconductor chip-based sequencing-by-synthesis instrument.
Genapsys plans to launch its electronic sensor-based sequencing system in the second half of this year.
Genapsys plans to launch the portable instrument in the second half of this year, and has signed on several early-access customers.
Meridian CEO Jack Kenny said the firm needs to develop a new MDx platform, while Genapsys resurfaced with an update on its portable sequencing platform.
Sigma-Aldrich has been developing reagents for the Genius platform for about a year.
This article was originally published February 17.
Science reports that a new White House Office of Management and Budget memo rescinds previous ones that helped research institutions deal with pandemic-related closures.
Researchers report on a concerning strain of the H1N1 swine flu virus found among pigs in China, Agence France Presse reports.
The Associated Press reports that US officials are considering allowing pooled COVID-19 testing.
In Genome Research this week: Y chromosome gene expression analysis, de novo mutations rise with paternal age in rhesus macaques, and more.